Drugs / THYROX
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06151548 | Mar → Jun 2024 | disorder of defective peroxisome oxidative status, erythrocyte disorder, iron metabolism disease | Poznan University of Physical Education | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | THYROX | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06151548 ↗ |
| Known as | Atlantic krill oil | “a supplement called THYROX (Atlantic krill oil)” NCT06151548 ↗ |